Public backs the NHS App but is wary of AI ‘doctor in your pocket’. Learn how data governance, cyber security and targeted investment can build trust.
Public Trust and AI in UK Healthcare: How to Win Acceptance Read More »
How pharma can convert fragmented legacy data into a living scientific memory to accelerate AI-driven drug discovery and secure lasting competitive advantage.
AI Drug Discovery’s Hidden Power: Transforming Legacy Data into Living Scientific Memory Read More »
A Health Foundation study shows uneven public and NHS staff views on AI in UK healthcare. Safety, human oversight and tailored engagement are needed to build trust and avoid widening inequalities.
Public & Staff Divide: Trust and the Future of AI in UK Healthcare Read More »
Eli Lilly teams with Nvidia to build Lillypod, a supercomputer strategy to speed AI-driven drug discovery and reshape the pharmaceutical lifecycle.
Eli Lilly and Nvidia Launch Lillypod to Accelerate AI Drug Discovery Read More »
How AI is streamlining patient access, speeding diagnostics, and powering personalized treatments for better outcomes across health systems.
AI Healthcare’s Latest Strides: Driving Efficiency and Innovation in Patient Care Read More »
How AI is changing diagnostics: benefits in radiology and pathology, risks like bias and automation bias, and practical steps for safe, clinician-centered adoption.
AI in Diagnostics: Progress, Challenges, and Responsible Integration Read More »
A concise, expert brief on how AI is reshaping diagnostics in radiology and pathology, its measurable benefits, main risks, and a practical governance roadmap.
AI in Healthcare Diagnostics: Practical Guide for Clinicians and Leaders Read More »
New AI-driven CSF liquid biopsy reads DNA methylation with M-PACT to identify brain tumors noninvasively. High accuracy, strong potential for pediatric care.
AI-Powered CSF Liquid Biopsy for Brain Tumors: M-PACT Breakthrough Read More »
Explore how AI can transform NHS patient access, strengthen cybersecurity, and power preventive health and workforce support across the UK health system.
AI in UK Healthcare: Solving Digital Access, Cyber Risk and Preventive Care Gaps Read More »
AI in drug discovery is set to grow 25-30% over five years. Read a concise briefing on drivers, key applications like oncology, major innovations and remaining hurdles.
AI in Drug Discovery: Trends, Partnerships and the Road Ahead Read More »
